comprehensive -WSS

comprehensive

author：knowledge 2025-08-25 07:29:14 - browse：12867

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： STAT Readout: Today's biotech news includes Sana and Amylyx

hotspot

WSS

Takeaways from AdvaMed, the largest medical devices conference

Generative AI mines health records to identify patients’ social needs

Akero's treatment for NASH falls short in cirrhosis study

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Better Therapeutics data on benefit with GLP

Heart disease and mental health: A look at cardiac psychology

knowledge

comprehensive

focus

Jerome Adams on the need for new antivirals for Covid

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Activists slam private health insurers over coverage restrictions

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

New air purifier tech could be key to improving indoor air quality

The SUPPORT Act is critical to fighting the opioid crisis

Sports medicine is finally prioritizing gender equality

Female surgeons have lower rates of long

Psychedelics group wrestles with new pharma identity

Heart disease and mental health: A look at cardiac psychology

focus

Heart disease and mental health: A look at cardiac psychology

A revolution in caring for preterm infants

Akero's treatment for NASH falls short in cirrhosis study

Readout LOUD podcast: Merger Mondays, Ozempic panic

Akero's treatment for NASH falls short in cirrhosis study

How doctors and nurses shape Google's AI

Wikipedia

hotspot

Wikipedia

Wikipedia